Skip to main content
Clinical Trials/CTRI/2024/07/070382
CTRI/2024/07/070382
Not yet recruiting
Phase 2

A randomized comparative clinical study to evaluate the efficacy of simhasyadi kwatha and patoladipanchanga kwatha in management of amlapitta - NI

Dr Vijayalakshmi Teggi0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Sponsor
Dr Vijayalakshmi Teggi
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Vijayalakshmi Teggi

Eligibility Criteria

Inclusion Criteria

  • 1\. Subject of either sex.
  • 2\. Subject within the age group 18\-60 yrs.
  • 3\. Subjects with clinical features of Amlapitta such as Avipaka, Klama, Uthklesha, Tikta Amlodgara, Gourava, Hruthkanta daha, and Aruchi will be included.
  • 4\. Subjects with controlled systemic disorder such as DM, HTN, etc will be included.
  • 5\. Subjects who are willing to give written consents for the study.

Exclusion Criteria

  • 1\. Pregnant and Lactating women
  • 2\. Subjects with uncontrolled systemic disorder such as Diabetes mellitus, Hypertension, etc
  • 3\. Subject diagnosed with Gastro\- intestinal disorders like peptic ulcer, pancreatic and hepatic disorders.
  • 4\. Subjects with history of haematemesis, malena and other systemic disorders that may interfere with the clinical trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials